+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis



Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis



Journal of Biological Chemistry 276(24): 21017-21021



Hamartin and tuberin are products of the tumor suppressor genes, TSC1 and TSC2, respectively. When mutated, a characteristic spectrum of tumor-like growths develop resulting in the syndrome of tuberous sclerosis complex. The phenotypes associated with TSC1 and TSC2 mutations are largely indistinguishable suggesting a common biochemical pathway. Indeed, hamartin and tuberin have been shown to interact stably in vitro and in vivo. Factors that regulate their interaction are likely critical to the understanding of disease pathogenesis. In this study, we showed that tuberin is phosphorylated at serine and tyrosine residues in response to serum and other factors, and it undergoes serial phosphorylation that can be detected by differences in electrophoretic mobilities. A disease-related TSC2 mutation (Y1571H) nearly abolished tuberin phosphorylation when stimulated with pervanadate. Expression of this mutant tuberin caused a marked reduction in TSC1-TSC2 interaction compared with wild-type protein and significantly curtailed the growth inhibitory effects of tuberin when overexpressed in COS1 cells, consistent with a loss of function mutation. Examination of a second pathologic mutation, P1675L, revealed a similar relationship between limited phosphorylation and reduced interaction with hamartin. Our data show for the first time that 1) tuberin is phosphorylated at tyrosine and serine residues, 2) TSC1-TSC2 interaction is regulated by tuberin phosphorylation, and 3) defective phosphorylation of tuberin is associated with loss of its tumor suppressor activity. These findings suggest that phosphorylation may be a key regulatory mechanism controlling TSC1-TSC2 function.

(PDF emailed within 0-6 h: $19.90)

Accession: 011598410

Download citation: RISBibTeXText

PMID: 11290735

DOI: 10.1074/jbc.c100136200


Related references

Distribution between monomeric and heteromeric forms of tuberin in association with hamartin, two proteins involved in tuberous sclerosis. Journal of Investigative Medicine 48(1): 80A, 2000

Developmental expression of the tuberous sclerosis proteins tuberin and hamartin. Acta Neuropathologica 101(3): 202-210, 2001

Definition of domains mediating interaction between hamartin and tuberin and disruption by tuberous sclerosis associated mutations. Journal of Medical Genetics 37(Supplement 1): S23, 2000

Interaction between hamartin and tuberin, the protein products of the TSC1 and TSC2 genes mutated in Tuberous Sclerosis. European Journal of Human Genetics 6(SUPPL 1): 116, 1998

The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutation Research 658(3): 234-246, 2008

Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin. Archives of Biochemistry & Biophysics 404(2): 210-217, August 15, 2002

Cellular co-localization of hamartin and tuberin and early hamartoma formation in tuberous sclerosis. Laboratory Investigation 82(1): 314A, 2002

Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas. Journal of Cutaneous Pathology 30(3): 174-177, 2003

Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin. Pediatric and Developmental Pathology 5(5): 448-464, 2002

Tuberous Sclerosis: Immunohistochemistry Expression Of Tuberin And Hamartin In A 31-Week Gestational Fetus. Fetal & Pediatric Pathology 23(4): 241-249, 2004

Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Acta Neuropathologica 99(5): 503-510, 2000

Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus. Fetal and Pediatric Pathology 23(4): 241-249, 2005

Hamartin, the product of the tuberous sclerosis 1 gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Research 58(21): 4766-4770, Nov 1, 1998

Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. Journal of Biological Chemistry 291(43): 22848, 2016

Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. Journal of Biological Chemistry 277(38): 35364-35370, 2002